Boston Scientific has pulled global sales of, and is no longer seeking FDA approval for, its Acurate neo2 and Acurate Prime aortic valve systems. In a May 28 Securities and Exchange Commission filing, ...

On May 28, 2025, analyst Mike Matson reaffirmed a “Buy” rating for Boston Scientific, sticking with a $115 price target. This ...

Boston Scientific ends global sales of ACURATE valves and halts FDA pursuit, citing rising regulatory burdens; expects to ...

Boston Scientific Corporation (BSX ... Marshall Wace LLP, a prominent hedge fund, holds a substantial stake in BSX, valued at nearly $792 million as of Q4 2024. The company, which specializes in ...

Boston Scientific’s recent financial report revealed that its electrophysiology sales grew 172% in Q4 2024, driven by an uptake of Farapulse. According to GlobalData analysis, since the FDA approval ...

Today we are looking at Boston Scientific (NYSE:BSX ... devices & supplies - diversified stocks we track reported a mixed Q4. As a group, revenues beat analysts’ consensus estimates by 1.4 ...

Boston Scientific Corporation (NYSE:BSX) Q4 2024 Earnings Call Transcript February 5, 2025 Operator: Good morning, and welcome to the Boston Scientific Fourth Quarter 2024 Earnings Call.

For more information, please refer to the Q4 financial and operational highlights deck ... including the Risk Factors section of our most recent annual report on Form 10-K. Boston Scientific disclaims ...

For more information, please refer to the Q4 financial and operational highlights ... of our most recent annual report on Form 10-K. Boston Scientific disclaims any intention or obligation to ...

Image credit: Shutterstock / Sundry Photography. Boston Scientific reported that electrophysiology sales grew 172% in Q4 2024, driven by an uptake of its Farapulse pulsed field ablation (PFA) system.

Investing.com -- Boston Scientific (NYSE:BSX) reported fiscal Q4 2024 results that surpassed analyst expectations. The company’s shares swung between gains and losses in premarket trading Wednesday.